Obtaining Evidence on Access to Essential Antibiotics in Immigrant and Refugee Populations
[ad_1]
Antimicrobial resistance (AMR) is a complex global health problem with significant impacts on human health, social welfare and economic development.
On 6 September 2022, WHO will host a high-level webinar to present and share findings from the Global Evidence Review on Health and Migration (GEHM) focusing on AMR. This report, the fourth in the GEHM series, examines the evidence on access to and use of essential antimicrobials in international migrant and refugee populations, providing guidance in addressing national and global challenges related to AMR and migration. Provides policy considerations to assist policy makers.
Launched June 17, 2021, the GEHM series is an evidence-based, prescriptive product that addresses policy questions around immigration-related public health priorities. The GEHM series also addresses knowledge gaps and summarizes the best available evidence worldwide to propose policy considerations for health conditions and health policies relevant to refugees and migrants.
The upcoming GEHM on AMR is the result of an intersectoral collaboration between WHO’s Health and Migration Program (PHM) and the Surveillance, Prevention and Control (SPC) Branch of the Antimicrobial Resistance Service (AMR). The PHM and SPC/AMR divisions have partnered with WHO Regional Offices, the International Organization for Migration (IOM), the United Nations High Commissioner for Refugees (UNHCR), Médecins Sans Frontières (MSF) and ReAct to identify supporting evidence Did. The focus is on identifying case studies and best practices for policy considerations and interventions.
audience
The event is open to all, but is specifically aimed at high-level policy makers, including ministries of health, health sector managers, academic institutions, and other key stakeholders.
agenda
The event will take place on Tuesday, September 6, 2022 from 14:00 to 15:00 CEST (Time Zone Coordinator).
Opening remarks
- Dr. Hanan Barkey, Assistant Director, Antimicrobial Resistance (AMR)
technical session
Chair – Rifat Hossain, Data and Evidence, Health and Migration Program (PHM)
The strategic importance of the Global Evidence Review on Health and Migration (GEHM) for policymaking for refugees and migrants
- Dr. Palmira Immordino, Data and Evidence, PHM
Obtaining Evidence on Access to Essential Antibiotics in Immigrant and Refugee Populations
- Dr. Susan Rogers Van Katwyk, Managing Director, WHO Collaborating Center on Global Governance of Antimicrobial Resistance
Developing a “people-centred framework” to address antimicrobial resistance (AMR)
- Mr. Anand Balachandran, AMR, Head of SPC Unit – National Action Planning and Monitoring
open discussion
- Dr Enrique Castro Sanchez, Associate Professor of Infection Prevention and Remediation, Department of Nursing, Midwifery and Health Care, University of West London, facilitated
Closing remarks
- Dr. Santino Severoni, PHM, WHO Director
- Dr. Catharina Van Weezenbeek, SPC/AMR Director
[ad_2]
Source link
